Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

NCT05619653 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

279

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Associated Cardiac Involvement
Remodeling, Left Ventricle
Remodeling, Vascular
Left Ventricular Dysfunction
Exercise Intolerance
Vascular Inflammation
Microvascular Angina
Long COVID
Myocarditis, Pericarditis

Interventions

DRUG: Prednisolone
DRUG: Losartan

Sponsor

Valentina Puentmann

Collaborators

[object Object]
[object Object]